Search

Your search keyword '"M. José Terol"' showing total 4 results
Start Over Author "M. José Terol" Topic cancer research
4 results on '"M. José Terol"'

1. UPDATED RESULTS OF A PHASE 2 STUDY FROM GELTAMO INVESTIGATING THE COMBINATION OF IBRUTINIB WITH R‐GEMOX IN PATIENTS WITH RELAPSED OR REFRACTORY DIFFUSE LARGE B‐CELL LYMPHOMA

Author

R. Andreu, B. Rey Búa, Eva Giné, J. J. Sánchez Blanco, F. de la Cruz, A. Martín García-Sancho, I. Zeberio Etxetxipia, Án. Ramírez‐Páyer, MJ Peñarrubia, Arantxa Gutiérrez, C. Grande, Santiago Montes-Moreno, Miguel Ángel Ramírez, Pau Abrisqueta, M. D. Caballero Barrigón, Ana Jiménez-Ubieto, Maria Cruz Viguria, A. De la Fuente, and M. José Terol

Subjects
Oncology, Cancer Research, medicine.medical_specialty, business.industry, Phases of clinical research, Hematology, General Medicine, GemOx, chemistry.chemical_compound, chemistry, Internal medicine, Ibrutinib, Medicine, Refractory Diffuse Large B-Cell Lymphoma, In patient, business
Published
2021
Full Text
View/download PDF

2. IBRUTINIB FOLLOWED BY OFATUMUMAB CONSOLIDATION IN PREVIOUSLY UNTREATED PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA (CLL): GELLC‐7 TRIAL FROM THE SPANISH GROUP OF CLL (GELLC)

Author

Eduardo Ríos, Eva González-Barca, Raul Cordoba, R. Andreu, Án. Ramírez Páyer, M. González, J. Án. Hernández-Rivas, M. Belén Vidriales, L.F. Casado, C Moreno, José A. García-Marco, Lucrecia Yáñez, Cristina Ballester, Pau Abrisqueta, Jose Antonio Delgado, Francesc Bosch, Patricia Baltasar, M. José Terol, Christelle Ferra, J. De la Serna, and M. Fernández de la Mata

Subjects
Oncology, Cancer Research, medicine.medical_specialty, business.industry, Chronic lymphocytic leukemia, Hematology, General Medicine, Ofatumumab, medicine.disease, chemistry.chemical_compound, chemistry, Internal medicine, Ibrutinib, medicine, business
Published
2021
Full Text
View/download PDF

3. Mutations in the RAS-BRAF-MAPK-ERK pathway define a specific subgroup of patients with adverse clinical features and provide new therapeutic options in chronic lymphocytic leukemia

Author

Ferran Nadeu, Laura Magnano, Estella Matutes, Elias Campo, M. José Terol, Xose S. Puente, Blanca Navarro, Marta Aymerich, Enrique Colado, Carlos López-Otín, Eva Giné, Marcos González, Laia Rosich, Angel Ramirez Payer, María Rozman, Alejandra Martínez-Trillos, Julio Delgado, Arnau Montraveta, Dolors Colomer, Miguel Alcoceba, Armando López-Guillermo, Juan G. Valero, Neus Giménez, Tycho Baumann, Neus Villamor, Mónica López-Guerra, and Universitat de Barcelona

Subjects
Adult, Male, Proto-Oncogene Proteins B-raf, Neuroblastoma RAS viral oncogene homolog, MAPK/ERK pathway, Adolescent, MAP Kinase Signaling System, Chronic lymphocytic leukemia, medicine.disease_cause, Article, Young Adult, 03 medical and health sciences, 0302 clinical medicine, Cell Line, Tumor, Ulixertinib, Biomarkers, Tumor, Humans, Medicine, Chronic Lymphocytic Leukemia, Leucèmia limfocítica crònica, Vemurafenib, Protein Kinase Inhibitors, Aged, Cell Proliferation, Aged, 80 and over, Mutation, business.industry, Gene Expression Profiling, Mutació (Biologia), Computational Biology, Dabrafenib, Hematology, Middle Aged, Mutation (Biology), medicine.disease, Leukemia, Lymphocytic, Chronic, B-Cell, 3. Good health, Leukemia, ras Proteins, Cancer research, Female, Transcriptome, business, 030215 immunology, medicine.drug
Abstract

This study was supported by the Ministerio de Economía y Competitividad, Grant n. SAF2015-67633-R ,and PI16/00420 which are part of Plan Nacional de I+D+I and are co-financed by the European Regional Development Fund (FEDER-“Una manera de hacer Europa”) and the CERCA program from Generalitat Catalunya. European Union’s Seventh Framework Programme for research, technological development and demonstration under grant agreement n. 306240; Generalitat de Catalunya Suport Grups de Recerca AGAUR 2017-SGR1009, and Departament de Salut (SLT002-16-00350), Instituto de Salud Carlos III (ISCIII) International Cancer Genome Consortium for Chronic Lymphocytic Leukemia (ICGC-CLL Genome Project), and project PM15/00007, which is part of Plan Nacional de I+D+I and are co-financed by FEDER. NG is a recipient of a predoctoral fellowship from Agaur and EC is an Academia Researcher of the "Institució Catalana de Recerca i Estudis Avançats" (ICREA) of the Generalitat de Catalunya., Giménez, N., Martínez-Trillos, A., Montraveta, A., Lopez-Guerra, M., Rosich, L., Nadeu, F., Valero, J.G., Aymerich, M., Magnano, L., Rozman, M., Matutes, E., Delgado, J., Baumann, T., Gine, E., González, M., Alcoceba, M., Terol, M.J., Navarro, B., Colado, E., Payer, A.R., Puente, X.S., López-Otín, C., Lopez-Guillermo, A., Campo, E., Colomer, D., Villamor, N.

Published
2018
Full Text
View/download PDF

4. NOTCH1 mutations identify a genetic subgroup of chronic lymphocytic leukemia patients with high risk of transformation and poor outcome

Author

Lucia Conde, Dolors Colomer, Consuelo Rayon, Enrique Colado, Carlos López-Otín, Pedro Jares, Alejandra Martínez-Trillos, Alfons Navarro, M. José Terol, Angel Ramirez Payer, Tycho Baumann, Eva Giné, Víctor Quesada, Belen Navarro, M Aymerich, M. Pinyol, Cristina López, Pau Abrisqueta, Arturo Pereira, J M Hernández, Marcos González-Díaz, Neus Villamor, Maite Cazorla, Sílvia Beà, Xose S. Puente, Francesc Bosch, María Rozman, Julio Delgado, Armando López-Guillermo, and Elias Campo

Subjects
Male, Risk, Oncology, Cancer Research, medicine.medical_specialty, Chronic lymphocytic leukemia, Disease, CD38, Biology, medicine.disease_cause, hemic and lymphatic diseases, Internal medicine, medicine, Humans, Receptor, Notch1, Prospective cohort study, Mutation, Hematology, Middle Aged, medicine.disease, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Cell Transformation, Neoplastic, embryonic structures, Immunology, cardiovascular system, Female, biological phenomena, cell phenomena, and immunity, Trisomy, IGHV@
Abstract

This study was supported by research funding from (Spanish Ministry of Science and Innovation MICINN) through the Instituto de Salud Carlos III (ISCIII) and Red Temática de Investigación del Cáncer (RTICC) (RD06-0020-0039 to E Campo and RD06-0020-0051 to AL-G), Fondo de investigaciones sanitarias (PI07/0301, MA) and Botín Foundation (CL-O)., Villamor, N., Conde, L., Martínez-Trillos, A., Cazorla, M., Navarro, A., Beà, S., López, C., Colomer, D., Pinyol, M., Aymerich, M., Rozman, M., Abrisqueta, P., Baumann, T., Delgado, J., Giné, E., González-Díaz, M., Hernández, J.M., Colado, E., Payer, A.R., Rayon, C., Navarro, B., JoséTerol, M., Bosch, F., Quesada, V., Puente, X.S., López-Otín, C., Jares, P., Pereira, A., Campo, E., López-Guillermo, A.

Published
2012
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results